| Main Title |
EPA inaction in identifying hazardous waste pharmaceuticals may result in unsafe disposal / |
| Other Authors |
|
| Publisher |
U.S. Environmental Protection Agency, Office of Inspector General, |
| Year Published |
2012 |
| OCLC Number |
798729704 |
| Subjects |
Drugs--Environmental aspects ;
Organic water pollutants ;
Water--Pollution--United States
|
| Internet Access |
|
| Holdings |
| Library |
Call Number |
Additional Info |
Location |
Last
Modified |
Checkout
Status |
| ELBD NSCEP |
EPA 12-P-0508 |
Online only via NSCEP - no print copies available |
AWBERC Library/Cincinnati,OH |
08/21/2019 |
|
| Collation |
[v], 30 pages ; 28 cm |
| Notes |
"Report No. 12-P-0508." "May 25, 2012." Printout of .pdf file. |
| Contents Notes |
"The discovery of a variety of pharmaceuticals in water has raised concerns about potentially adverse environmental consequences of these contaminants. Studies have suggested the detection of pharmaceutical compounds in treated wastewater effluent, streams, lakes, seawater, drinking water, and groundwater, as well as in sediments and fish tissue. EPA has the authority under the Resource Conservation and Recovery Act (RCRA) to regulated hazardous waste pharmaceuticals (HWPs) to ensure safe management and disposal practices."--Background. |
